Tandem Diabetes Care looks north

Friday, February 23, 2018

SAN DIEGO – Tandem Diabetes Care, a manufacturer of touchscreen insulin pumps, has submitted a medical device license application to Health Canada to market its t:slim X2 Insulin Pump with Dexcom G5 Mobile continuous glucose monitoring integration. The company plans to launch the pump in Canada in the second half of 2018, subject to regulatory approvals. “This application is another important step toward achieving our strategic goal of bringing the benefits of the t:slim X2 Insulin Pump to people outside of the United States," said Kim Blickenstaff, president and CEO of Tandem Diabetes Care. The company anticipates that the t:slim X2 Insulin Pump offered in Canada will be capable of displaying both English and French, will offer a 24-hour clock, and will display glucose readings in millimoles per liter (mmol/L).